시장보고서
상품코드
1181683

세계의 웨어러블 심전계 시장 : 전망과 예측(2022-2027년)

Wearable ECG Devices Market - Global Outlook & Forecast 2022-2027

발행일: | 리서치사: Arizton Advisory & Intelligence | 페이지 정보: 영문 280 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 웨어러블 심전계 시장 규모는 2021-2027년에 CAGR로 약 19.32%의 성장이 예측됩니다.

세계의 웨어러블 심전계 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인, 경쟁 구도 등을 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 조사 목적

제3장 조사 프로세스

제4장 범위

제5장 리포트 전제조건과 주의사항

제6장 시장의 개요

제7장 서론

제8장 주요 인사이트

  • 시장 시나리오
    • 개요
    • 시장 세분화

제9장 시장 기회와 동향

제10장 시장 성장 촉진요인

제11장 시장 성장 억제요인

제12장 시장 구도

  • 시장의 개요
  • 시장 규모와 예측
    • 지역 인사이트
    • 제품 인사이트
    • 주파수 인사이트
  • Five forces 분석

제13장 제품

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 스마트워치 기반 심전도
  • 모바일 심장 텔레메트리
  • 홀터 모니터링
  • 심장 이벤트 모니터링

제14장 주파수

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 에피소드·애드혹
  • 연속

제15장 지역

  • 시장 스냅숏과 성장 엔진
  • 지역적 개요

제16장 북미

  • 시장의 개요
    • 시장 규모와 예측
    • 북미 : 제품별
    • 북미 : 주파수별
  • 주요 국가
    • 미국 : 시장 규모와 예측
    • 캐나다 : 시장 규모와 예측

제17장 유럽

  • 시장의 개요
    • 시장 규모와 예측
    • 유럽 : 제품별
    • 유럽 : 주파수별
  • 주요 국가
    • 독일 : 시장 규모와 예측
    • 프랑스 : 시장 규모와 예측
    • 영국 : 시장 규모와 예측
    • 이탈리아 : 시장 규모와 예측
    • 스페인 : 시장 규모와 예측

제18장 아시아태평양

  • 시장의 개요
    • 시장 규모와 예측
    • 아시아태평양 : 제품별
    • 아시아태평양 : 주파수별
  • 주요 국가
    • 일본 : 시장 규모와 예측
    • 중국 : 시장 규모와 예측
    • 인도 : 시장 규모와 예측
    • 한국 : 시장 규모와 예측
    • 호주 : 시장 규모와 예측

제19장 라틴아메리카

  • 시장의 개요
    • 시장 규모와 예측
    • 라틴아메리카 : 제품별
    • 라틴아메리카 : 주파수별
  • 주요 국가
    • 브라질 : 시장 규모와 예측
    • 멕시코 : 시장 규모와 예측
    • 아르헨티나 : 시장 규모와 예측

제20장 중동·아프리카

  • 시장의 개요
    • 시장 규모와 예측
    • 중동·아프리카 : 제품별
    • 중동·아프리카 : 주파수별
  • 주요 국가
    • 터키 : 시장 규모와 예측
    • 사우디아라비아 : 시장 규모와 예측
    • 남아프리카공화국 : 시장 규모와 예측

제21장 경쟁 구도

  • 경쟁의 개요
  • 시장 점유율 분석

제22장 ECG 기반 스마트워치 : 주요 기업 개요

  • APPLE
  • ALPHABET
  • SAMSUNG ELECTRONICS
  • WITHINGS

제23장 기타 웨어러블 심전계 : 주요 기업 개요

  • BOSTON SCIENTIFIC
  • GE HEALTHCARE
  • IRHYTHM TECHNOLOGIES
  • HILL-ROM
  • KONINKLIJKE PHILIPS
  • OSI SYSTEMS

제24장 기타 유명 벤더

  • AEROTEL MEDICAL SYSTEMS
  • ADVANCED INSTRUMENTATIONS
  • AMEDTEC MEDIZINTECHNIK AUE
  • ASPEL
  • BPL MEDICAL TECHNOLOGIES
  • BARDY DIAGNOSTICS
  • BITTIUM
  • BIOTRICITY
  • BORSAM BIOMEDICAL INSTRUMENTS
  • BTL
  • CARDIACSENSE
  • CORTRIUM
  • CONTEC MEDICAL SYSTEMS
  • CUSTO MED
  • DMS-SERVICE
  • EB NEURO
  • EDAN INSTRUMENTS
  • FUKUDA DENSHI
  • FOREST MEDICAL
  • HANGZHOU BENEWARE MEDICAL EQUIPMENT
  • HOLTER SUPPLIES
  • LABTECH
  • LEPU MEDICAL TECHNOLOGY
  • LIVEWELL
  • LUMED
  • MASIMO
  • MEDICALGORITHMICS
  • MEDICAL ECONET
  • MEDICOMP
  • MEDITECH KFT
  • MEDITECH EQUIPMENT
  • MIDMARK
  • MONITOR
  • NASAN MEDICAL ELECTRONICS
  • NASIFF ASSOCIATES
  • NEUROSOFT
  • NORAV MEDICAL
  • NORTHEAST MONITORING
  • OY DIAGNOSTIC DEVICES DEVELOPMENT - DDD
  • RECORDERS & MEDICARE SYSTEMS
  • SCOTTCARE CARDIOVASCULAR SOLUTIONS
  • SCHILLER
  • SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT
  • SUZUKEN COMPANY
  • TRIMPEKS
  • UPOLIFE
  • VIVALNK

제25장 리포트 요약

  • 주요 사항
  • 전략적 권장사항

제26장 정량적 요약

제27장 부록

KSA 23.01.19

The global wearable ECG devices market is expected to grow at a CAGR of approximately 19.32% from 2021 to 2027

MARKET TRENDS & DRIVERS

Increasing Usage of Advanced Sensors & Artificial Intelligence in Wearable ECG Devices

a) Artificial intelligence (AI) and wearable sensors are two rapidly evolving healthcare technologies poised to transform cardiac care. Together, these technologies enable high-quality electrocardiogram (ECG) acquisition and automatic signal interpretation with cardiologist-level accuracy. Various arrhythmias, such as atrial fibrillation (AF), are detectable, and their diagnosis has important therapeutic implications and may improve patient outcomes.

b) Mobile ECG sensors are integrated into wearable devices like smartwatches (Apple Watch, AliveCor Kardia), patches (iRhythm Zio), bands (Fitbit Sense), necklaces (toSense CoVa), clothing, rings, and other wearable forms. Key considerations for device selection include electrode type and configuration, storage capacity, power consumption, battery life, signal processing electronics, and wireless communication capabilities. Most mobile RM devices use a 1-lead ECG configuration for ease of use, but six or more lead configurations (such as the AliveCor KardiaMobile 6L) are also available. The emergence of advanced sensors, AI, ML, and DL in wearable ECG is boosting the wearable ECG devices market.

The Emergence Of Smartwatches Equipped With ECG

a) One of the biggest health features in smartwatches today is the ECG feature. EKG stands for Electrocardiogram and is sometimes abbreviated as EKG. A medical procedure that measures heart activity to check for abnormalities. An electrocardiogram taken in a hospital would require a more detailed reading. Still, the advantage of equipping smartwatches with similar hardware is that the owner can take an electrocardiogram at any time and provide that data to the doctor. The Apple Watch (Series 4, 5, and 6) features an FDA-cleared ECG app that captures 30-second electrocardiogram segments and then analyzes normal rhythm and AF using the user's smartphone.

b) Similarly, the Fitbit Sense is another smartwatch-type device with FDA clearance for AF detection. The Samsung Galaxy Watch3 and Galaxy Watch Active2 also include an FDA-cleared ECG monitoring function that includes screening for AF. With the help of built-in connectivity technologies and apps, smartwatches frequently combine ECG data with monitoring other physiologic indicators. They also feature streamlined data storage and transmission capabilities. Such integration of ECG with smartwatches contributes to the growth of the wearable ECG devices market.

The Paradigm Shift from Conventional ECG Towards Ambulatory ECG

a) Ambulatory monitors enable a new paradigm in healthcare by collecting and analyzing long-term data for a reliable diagnosis. These devices are becoming increasingly popular for continuous cardiac monitoring. Advances in hardware and software have created new devices that are convenient and affordable. This allows vulnerable people to be monitored from the comfort of their own homes while providing critical alerts about events requiring urgent medical attention or hospitalization. The essential advantage of wearable ECG devices is that one can continue daily activities while the heart is being monitored.

b) Wearable ambulatory monitoring devices, including Holter monitors, are mainly embedded with electrocardiogram sensors for monitoring irregular heartbeats. It is challenging for the HCPs to detect arrhythmic disorders with conventional ECG due to their characteristic of intermittent short episodes. Holter monitors can overcome the challenge faced by conventional ECG devices of low successful diagnosis outcomes. Owing to the benefits of ambulatory monitoring, wearable ECG devices market players are significantly focusing on developing user-friendly, safe & accurate ambulatory ECG devices. For instance, introducing the latest-generation patch-based Holter monitors can be worn up to a few weeks instead of 24/48 hours while offering the greatest patient comfort.

SEGMENTATION ANALYSIS

INSIGHT BY PRODUCT

The smartwatch-based ECG accounted for the largest share of 83.31% in the global wearable ECG devices market in 2021 under the product segment. The higher share can be attributed to the biggest health feature in smartwatches today, the ECG feature. Apple, a key player in smartwatch-based ECG, released its first smartwatch in 2018 and received FDA clearance for automatic AF detection. Still, smartwatches from other leading players such as Samsung, Withings, and Alphabet (Fitbit) also take ECG recordings and alert the wearer when AF is detected. The process of acquiring an electrocardiogram, analyzing it to produce an automated diagnosis of AF, and providing options for communicating those results to the wearer's physician is similar across smartwatch makers. In September 2022, Apple launched Apple Watch Series 8 and the new Apple Watch SE. The ECG app can record the user's heartbeat and rhythm using the pioneering electrical heart sensor on the company's Watch Series 4, Series 5, Series 6, Series 7, Series 8, or ultra and then check the recording for AF, a form of irregular rhythm.

Segmentation By Product

  • Smartwatch-Based ECG
  • Mobile Cardiac Telemetry
  • Holter Monitoring
  • Cardiac Event Monitoring

INSIGHTS BY FREQUENCY

The global wearable ECG devices market is segmented into episodic & Adhoc and continuous by frequency segmentation. The global wearable ECG devices market by episodic & Adhoc market is expected to reach USD 22.28 billion by 2027, growing at a CAGR of 19.48% during the forecast period. Ad-hoc (i.e., one-time) fixed monitoring has been used in many research studies to address different medical settings using different types of ECG sensors and monitoring platforms. Several investigators emphasized that ad hoc non-ambulatory monitoring may reduce the burden of post-ablation outpatient visits and atrial fibrillation-related hospital visits. As the smartwatch-based ECG is the leading segment and has the largest share, 83.31%, in the global wearable ECG devices market, the episodic & ad hoc segment is also the largest share, 62.36% in the global wearable ECG devices market.

Segmentation By Frequency

  • Episodic & Adhoc
  • Continuous

GEOGRAPHICAL ANALYSIS

a) North America accounted for the largest share of 34.08% in the global wearable ECG devices market in 2021 and is likely to witness the highest incremental growth of around USD 9.01 billion during the forecast period. The US is the major revenue contributor to the North American wearable ECG devices market and accounted for a share of 91.30% in 2021. The growth in the region is mainly attributed to the increasing incidence of AF, CVDs such as CAD, surge in diagnosis procedures for treating such diseases. The availability of advanced wearable ECG devices developers, constant technological innovations, and growing acceptance of technologically advanced wearable ECG devices further accelerate the region's market growth.

b) The wearable ECG devices market in APAC is growing significantly and is expected to grow at a similar pace during the forecast period. Some factors contributing to this region's growth are a large pool of patient population, improvements in healthcare infrastructure, and increased healthcare expenditure. Further, the increasing prevalence of cardiac diseases, including AF, the aging population, and the smart wearable adoption trends among the young generation are the key factors driving the wearable ECG devices market in the region.

c) In 2021, Europe accounted for 25.09% of the global wearable ECG devices market share. The rising awareness of ambulatory ECG devices for AF, and CVDs, coupled with improved healthcare infrastructure, various favorable guidelines, and the availability of technologically advanced ECG-based smartwatches, patch are driving the growth of the wearable ECG devices market in the region. Germany, France, the UK, Italy, and Spain are the major revenue generators in the region. These five countries of the ECG devices market collectively accounted for around 65.03% of the European wearable ECG devices market in 2021.

By Geography

  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • South Arabia

VENDOR LANDSCAPE

Vendors in the global wearable ECG device market are actively researching and commercializing their novel and advanced wearable ECG device. In the past five years, many vendors received regulatory approvals for their wearable ECG devices. For instance, Withings has received US FDA clearance for the launch of the ScanWatch in the US. The watch was launched in Europe and Australia in 2020 and released in the US in November 2021. In November 2020, VitalConnect, a leader in remote and in-hospital wearable biosensor technology companies, announced that it had launched its VitalPatch RTM cardiac monitoring solution for users who want to expand Holter monitoring. Vendors operating the wearable ECG device market are pursuing various strategies to provide the impetus for growth over the next few years. These market participants adopt collaboration, partnerships, mergers, acquisitions, product launches, and other strategies.

Recent Developments In The Global Wearable ECG Devices Market

  • In September 2022, Apple launched Apple Watch Series 8 and the new Apple Watch SE.
  • In April 2022, Biotricity, a medical diagnostic and healthcare technology player, launched the commercial sales of the Biotres, an FDA-approved wireless wearable extended Holter monitor for Up to 30-day wear duration.
  • In 2021, Philips acquired BioTelemetry, a leading vendor in the mobile cardiac telemetry segment.
  • In 2021, Boston Scientific acquired Preventice Solutions.
  • In December 2021, Baxter International acquired Hill-Rom Services.

ECG-Based Smartwatches: Key Company Profiles

  • Apple
  • Alphabet
  • Samsung Electronics
  • Withings

Other Wearable ECG Devices: Key Company Profiles

  • Boston Scientific
  • GE Healthcare
  • iRhythm Technologies
  • Hill-Rom
  • Koninklijke Philips
  • OSI Systems

Other Prominent Vendors

  • BPL Medical Technologies
  • Bardy Diagnostics
  • Bittium
  • CardiacSense
  • Cortrium
  • FUKUDA DENSHI
  • Masimo
  • Medicalgorithmics
  • Advanced Instrumentations
  • AMEDTEC MEDIZINTECHNIK AUE
  • ASPEL
  • Hangzhou Beneware Medical Equipment
  • Biotricity
  • Borsam Biomedical Instruments
  • BTL
  • Contec Medical System
  • Custo Med
  • Oy Diagnostic Devices Development - DDD
  • DMS-Service
  • EB-Neuro
  • Edan Instruments
  • Forest Medical
  • Holter Supplies
  • Labtech
  • LPU Medical
  • LIVEWELL
  • Lumed
  • medical ECONET
  • Medicomp
  • Meditech KFT
  • Meditech Equipment
  • Midmark
  • Monitor
  • Nasan Medical Electronics
  • Nasiff Associates
  • Neurosoft
  • Norav Medical
  • Northeast Monitoring
  • Recorders & Medicare Systems
  • Scottcare Cardiovascular Solutions
  • Schiller
  • Shenzhen Biocare Bio-Medical Equipment
  • Suzuken Company
  • Trimpeks
  • UPOLife
  • VivaLNK

KEY QUESTIONS ANSWERED

  • 1. How big is the wearable ECG devices market?
  • 2. What is the growth rate of the global wearable ECG devices market?
  • 3. Which region holds the most prominent global wearable ECG devices market share?
  • 4. Who are the global wearable ECG devices market's key players?
  • 5. What are the growth opportunities in the wearable ECG devices market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

  • 7.1 OVERVIEW
    • 7.1.1 WEARABLE ECG DEVICES

8 PREMIUM INSIGHTS

  • 8.1 MARKET SCENARIO
    • 8.1.1 OVERVIEW
    • 8.1.2 MARKET SEGMENTATION

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 INCREASING USE OF ADVANCED SENSORS & AI IN WEARABLE ECG DEVICES
  • 9.2 EMERGENCE OF SMARTWATCHES EQUIPPED WITH ECG
  • 9.3 NEW PRODUCT APPROVALS & LAUNCHES IN WEARABLE ECG DEVICES
  • 9.4 GROWING POPULARITY OF SMART WEARABLE TECHNOLOGY IN ECG

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASING GLOBAL PREVALENCE OF CARDIOVASCULAR DISEASES
  • 10.2 PARADIGM SHIFT FROM CONVENTIONAL ECG TOWARD AMBULATORY ECG
  • 10.3 HIGH DEMAND FOR MCT & NEXT-GENERATION HOLTER MONITORS

11 MARKET GROWTH RESTRAINTS

  • 11.1 LIMITATIONS & RISKS ASSOCIATED WITH WEARABLE ECG DEVICES
  • 11.2 HIGH COST OF WEARABLE ECG DEVICES
  • 11.3 AVAILABILITY OF ALTERNATE CARDIAC MONITORING DEVICES

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 GEOGRAPHY INSIGHTS
    • 12.2.2 PRODUCT INSIGHTS
    • 12.2.3 FREQUENCY INSIGHTS
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 SMARTWATCH-BASED ECG
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 MOBILE CARDIAC TELEMETRY
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 HOLTER MONITORING
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 CARDIAC EVENT MONITORING
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY

14 FREQUENCY

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 EPISODIC & ADHOC
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 CONTINUOUS
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

  • 16.1 MARKET OVERVIEW
    • 16.1.1 MARKET SIZE & FORECAST
    • 16.1.2 NORTH AMERICA: PRODUCT SEGMENTATION
    • 16.1.3 NORTH AMERICA: FREQUENCY SEGMENTATION
  • 16.2 KEY COUNTRIES
    • 16.2.1 US: MARKET SIZE & FORECAST
    • 16.2.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

  • 17.1 MARKET OVERVIEW
    • 17.1.1 MARKET SIZE & FORECAST
    • 17.1.2 EUROPE: PRODUCT SEGMENTATION
    • 17.1.3 EUROPE: FREQUENCY SEGMENTATION
  • 17.2 KEY COUNTRIES
    • 17.2.1 GERMANY: MARKET SIZE & FORECAST
    • 17.2.2 FRANCE: MARKET SIZE & FORECAST
    • 17.2.3 UK: MARKET SIZE & FORECAST
    • 17.2.4 ITALY: MARKET SIZE & FORECAST
    • 17.2.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

  • 18.1 MARKET OVERVIEW
    • 18.1.1 MARKET SIZE & FORECAST
    • 18.1.2 APAC: PRODUCT SEGMENTATION
    • 18.1.3 APAC: FREQUENCY SEGMENTATION
  • 18.2 KEY COUNTRIES
    • 18.2.1 JAPAN: MARKET SIZE & FORECAST
    • 18.2.2 CHINA: MARKET SIZE & FORECAST
    • 18.2.3 INDIA: MARKET SIZE & FORECAST
    • 18.2.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 18.2.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

  • 19.1 MARKET OVERVIEW
    • 19.1.1 MARKET SIZE & FORECAST
    • 19.1.2 LATIN AMERICA: PRODUCT SEGMENTATION
    • 19.1.3 LATIN AMERICA: FREQUENCY SEGMENTATION
  • 19.2 KEY COUNTRIES
    • 19.2.1 BRAZIL: MARKET SIZE & FORECAST
    • 19.2.2 MEXICO: MARKET SIZE & FORECAST
    • 19.2.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

  • 20.1 MARKET OVERVIEW
    • 20.1.1 MARKET SIZE & FORECAST
    • 20.1.2 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
    • 20.1.3 MIDDLE EAST & AFRICA: FREQUENCY SEGMENTATION
  • 20.2 KEY COUNTRIES
    • 20.2.1 TURKEY: MARKET SIZE & FORECAST
    • 20.2.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 20.2.3 SOUTH AFRICA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

  • 21.1 COMPETITION OVERVIEW
  • 21.2 MARKET SHARE ANALYSIS

22 ECG-BASED SMARTWATCHES: KEY COMPANY PROFILES

  • 22.1 APPLE
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 APPLE IN WEARABLE ECG DEVICES MARKET
    • 22.1.3 PRODUCT OFFERINGS
    • 22.1.4 KEY STRATEGIES
    • 22.1.5 KEY STRENGTHS
    • 22.1.6 KEY OPPORTUNITIES
  • 22.2 ALPHABET
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 ALPHABET IN WEARABLE ECG DEVICES MARKET
    • 22.2.3 PRODUCT OFFERINGS
    • 22.2.4 KEY STRATEGIES
    • 22.2.5 KEY STRENGTHS
    • 22.2.6 KEY OPPORTUNITIES
  • 22.3 SAMSUNG ELECTRONICS
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 SAMSUNG ELECTRONICS IN WEARABLE ECG DEVICES MARKET
    • 22.3.3 PRODUCT OFFERINGS
    • 22.3.4 KEY STRATEGIES
    • 22.3.5 KEY STRENGTHS
    • 22.3.6 KEY OPPORTUNITIES
  • 22.4 WITHINGS
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 WITHINGS IN WEARABLE ECG DEVICES MARKET
    • 22.4.3 PRODUCT OFFERINGS
    • 22.4.4 KEY STRATEGIES
    • 22.4.5 KEY STRENGTHS
    • 22.4.6 KEY OPPORTUNITIES

23 OTHER WEARABLE ECG DEVICES: KEY COMPANY PROFILES

  • 23.1 BOSTON SCIENTIFIC
    • 23.1.1 BUSINESS OVERVIEW
    • 23.1.2 BOSTON SCIENTIFIC IN WEARABLE ECG DEVICES MARKET
    • 23.1.3 PRODUCT OFFERINGS
    • 23.1.4 KEY STRATEGIES
    • 23.1.5 KEY STRENGTHS
    • 23.1.6 KEY OPPORTUNITIES
  • 23.2 GE HEALTHCARE
    • 23.2.1 BUSINESS OVERVIEW
    • 23.2.2 GE HEALTHCARE IN WEARABLE ECG DEVICES MARKET
    • 23.2.3 PRODUCT OFFERINGS
    • 23.2.4 KEY STRATEGIES
    • 23.2.5 KEY STRENGTHS
    • 23.2.6 KEY OPPORTUNITIES
  • 23.3 IRHYTHM TECHNOLOGIES
    • 23.3.1 BUSINESS OVERVIEW
    • 23.3.2 IRHYTHM TECHNOLOGIES IN WEARABLE ECG DEVICES MARKET
    • 23.3.3 PRODUCT OFFERINGS
    • 23.3.4 KEY STRATEGIES
    • 23.3.5 KEY STRENGTHS
    • 23.3.6 KEY OPPORTUNITIES
  • 23.4 HILL-ROM
    • 23.4.1 BUSINESS OVERVIEW
    • 23.4.2 HILL-ROM IN WEARABLE ECG DEVICES MARKET
    • 23.4.3 PRODUCT OFFERINGS
    • 23.4.4 KEY STRATEGIES
    • 23.4.5 KEY STRENGTHS
    • 23.4.6 KEY OPPORTUNITIES
  • 23.5 KONINKLIJKE PHILIPS
    • 23.5.1 BUSINESS OVERVIEW
    • 23.5.2 KONINKLIJKE PHILIPS IN WEARABLE ECG DEVICES MARKET
    • 23.5.3 PRODUCT OFFERINGS
    • 23.5.4 KEY STRATEGIES
    • 23.5.5 KEY STRENGTHS
    • 23.5.6 KEY OPPORTUNITIES
  • 23.6 OSI SYSTEMS
    • 23.6.1 BUSINESS OVERVIEW
    • 23.6.2 OSI SYSTEMS IN WEARABLE ECG DEVICES MARKET
    • 23.6.3 PRODUCT OFFERINGS
    • 23.6.4 KEY STRATEGIES
    • 23.6.5 KEY STRENGTHS
    • 23.6.6 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

  • 24.1 AEROTEL MEDICAL SYSTEMS
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 PRODUCT OFFERINGS
  • 24.2 ADVANCED INSTRUMENTATIONS
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 PRODUCT OFFERINGS
  • 24.3 AMEDTEC MEDIZINTECHNIK AUE
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 PRODUCT OFFERINGS
  • 24.4 ASPEL
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 PRODUCT OFFERINGS
  • 24.5 BPL MEDICAL TECHNOLOGIES
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 PRODUCT OFFERINGS
  • 24.6 BARDY DIAGNOSTICS
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 PRODUCT OFFERINGS
  • 24.7 BITTIUM
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 PRODUCT OFFERINGS
  • 24.8 BIOTRICITY
    • 24.8.1 BUSINESS OVERVIEW
    • 24.8.2 PRODUCT OFFERINGS
  • 24.9 BORSAM BIOMEDICAL INSTRUMENTS
    • 24.9.1 BUSINESS OVERVIEW
    • 24.9.2 PRODUCT OFFERINGS
  • 24.10 BTL
    • 24.10.1 BUSINESS OVERVIEW
    • 24.10.2 PRODUCT OFFERINGS
  • 24.11 CARDIACSENSE
    • 24.11.1 BUSINESS OVERVIEW
    • 24.11.2 PRODUCT OFFERINGS
  • 24.12 CORTRIUM
    • 24.12.1 BUSINESS OVERVIEW
    • 24.12.2 PRODUCT OFFERINGS
  • 24.13 CONTEC MEDICAL SYSTEMS
    • 24.13.1 BUSINESS OVERVIEW
    • 24.13.2 PRODUCT OFFERINGS
  • 24.14 CUSTO MED
    • 24.14.1 BUSINESS OVERVIEW
    • 24.14.2 PRODUCT OFFERINGS
  • 24.15 DMS-SERVICE
    • 24.15.1 BUSINESS OVERVIEW
    • 24.15.2 PRODUCT OFFERINGS
  • 24.16 EB NEURO
    • 24.16.1 BUSINESS OVERVIEW
    • 24.16.2 PRODUCT OFFERINGS
  • 24.17 EDAN INSTRUMENTS
    • 24.17.1 BUSINESS OVERVIEW
    • 24.17.2 PRODUCT OFFERINGS
  • 24.18 FUKUDA DENSHI
    • 24.18.1 BUSINESS OVERVIEW
    • 24.18.2 PRODUCT OFFERINGS
  • 24.19 FOREST MEDICAL
    • 24.19.1 BUSINESS OVERVIEW
    • 24.19.2 PRODUCT OFFERINGS
  • 24.20 HANGZHOU BENEWARE MEDICAL EQUIPMENT
    • 24.20.1 BUSINESS OVERVIEW
    • 24.20.2 PRODUCT OFFERINGS
  • 24.21 HOLTER SUPPLIES
    • 24.21.1 BUSINESS OVERVIEW
    • 24.21.2 PRODUCT OFFERINGS
  • 24.22 LABTECH
    • 24.22.1 BUSINESS OVERVIEW
    • 24.22.2 PRODUCT OFFERINGS
  • 24.23 LEPU MEDICAL TECHNOLOGY
    • 24.23.1 PRODUCT OFFERINGS
  • 24.24 LIVEWELL
    • 24.24.1 BUSINESS OVERVIEW
    • 24.24.2 PRODUCT OFFERINGS
  • 24.25 LUMED
    • 24.25.1 BUSINESS OVERVIEW
    • 24.25.2 PRODUCT OFFERINGS
  • 24.26 MASIMO
    • 24.26.1 BUSINESS OVERVIEW
    • 24.26.2 PRODUCT OFFERINGS
  • 24.27 MEDICALGORITHMICS
    • 24.27.1 BUSINESS OVERVIEW
    • 24.27.2 PRODUCT OFFERINGS
  • 24.28 MEDICAL ECONET
    • 24.28.1 BUSINESS OVERVIEW
    • 24.28.2 PRODUCT OFFERINGS
  • 24.29 MEDICOMP
    • 24.29.1 BUSINESS OVERVIEW
    • 24.29.2 PRODUCT OFFERINGS
  • 24.30 MEDITECH KFT
    • 24.30.1 BUSINESS OVERVIEW
    • 24.30.2 PRODUCT OFFERINGS
  • 24.31 MEDITECH EQUIPMENT
    • 24.31.1 BUSINESS OVERVIEW
    • 24.31.2 PRODUCT OFFERINGS
  • 24.32 MIDMARK
    • 24.32.1 BUSINESS OVERVIEW
    • 24.32.2 PRODUCT OFFERINGS
  • 24.33 MONITOR
    • 24.33.1 BUSINESS OVERVIEW
    • 24.33.2 PRODUCT OFFERINGS
  • 24.34 NASAN MEDICAL ELECTRONICS
    • 24.34.1 BUSINESS OVERVIEW
    • 24.34.2 PRODUCT OFFERINGS
  • 24.35 NASIFF ASSOCIATES
    • 24.35.1 BUSINESS OVERVIEW
    • 24.35.2 PRODUCT OFFERINGS
  • 24.36 NEUROSOFT
    • 24.36.1 BUSINESS OVERVIEW
    • 24.36.2 PRODUCT OFFERINGS
  • 24.37 NORAV MEDICAL
    • 24.37.1 BUSINESS OVERVIEW
    • 24.37.2 PRODUCT OFFERINGS
  • 24.38 NORTHEAST MONITORING
    • 24.38.1 BUSINESS OVERVIEW
    • 24.38.2 PRODUCT OFFERINGS
  • 24.39 OY DIAGNOSTIC DEVICES DEVELOPMENT - DDD
    • 24.39.1 BUSINESS OVERVIEW
    • 24.39.2 PRODUCT OFFERINGS
  • 24.40 RECORDERS & MEDICARE SYSTEMS
    • 24.40.1 BUSINESS OVERVIEW
    • 24.40.2 PRODUCT OFFERINGS
  • 24.41 SCOTTCARE CARDIOVASCULAR SOLUTIONS
    • 24.41.1 BUSINESS OVERVIEW
    • 24.41.2 PRODUCT OFFERINGS
  • 24.42 SCHILLER
    • 24.42.1 BUSINESS OVERVIEW
    • 24.42.2 PRODUCT OFFERINGS
  • 24.43 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT
    • 24.43.1 BUSINESS OVERVIEW
    • 24.43.2 PRODUCT OFFERINGS
  • 24.44 SUZUKEN COMPANY
    • 24.44.1 BUSINESS OVERVIEW
    • 24.44.2 PRODUCT OFFERINGS
  • 24.45 TRIMPEKS
    • 24.45.1 BUSINESS OVERVIEW
    • 24.45.2 PRODUCT OFFERINGS
  • 24.46 UPOLIFE
    • 24.46.1 BUSINESS OVERVIEW
    • 24.46.2 PRODUCT OFFERINGS
  • 24.47 VIVALNK
    • 24.47.1 BUSINESS OVERVIEW
    • 24.47.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

  • 25.1 KEY TAKEAWAYS
  • 25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

  • 26.1 MARKET BY PRODUCT
    • 26.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
    • 26.1.2 EUROPE: PRODUCT SEGMENTATION
    • 26.1.3 APAC: PRODUCT SEGMENTATION
    • 26.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
    • 26.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
  • 26.2 MARKET BY FREQUENCY
    • 26.2.1 NORTH AMERICA: FREQUENCY SEGMENTATION
    • 26.2.2 EUROPE: FREQUENCY SEGMENTATION
    • 26.2.3 APAC: FREQUENCY SEGMENTATION
    • 26.2.4 LATIN AMERICA: FREQUENCY SEGMENTATION
    • 26.2.5 MIDDLE EAST & AFRICA: FREQUENCY SEGMENTATION
  • 26.3 MARKET BY GEOGRAPHY
    • 26.3.1 SMARTWATCH-BASED ECG: GEOGRAPHY SEGMENTATION
    • 26.3.2 MOBILE CARDIAC TELEMETRY: GEOGRAPHY SEGMENTATION
    • 26.3.3 HOLTER MONITORING: GEOGRAPHY SEGMENTATION
    • 26.3.4 CARDIAC EVENT MONITORING: GEOGRAPHY SEGMENTATION
    • 26.3.5 EPISODIC & ADHOC: GEOGRAPHY SEGMENTATION
    • 26.3.6 CONTINUOUS: GEOGRAPHY SEGMENTATION

27 APPENDIX

  • 27.1 ABBREVIATIONS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제